Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close

RELATED INFORMATION

KEY CONTACTS

UPCOMING EVENTS

RELATED PRODUCTS

Medical Products & Devices

Highlights
Research
Organizations
Please refine your search by Market Segment to get corresponding Rating Activity and Watchlist
Enter download charge code:
Title:
Published:
Document Type:
................................................................................................................................
Please input the charge code.
Charge Code:
Add alert for this criteria Add alert for this criteria
View All
  DateDocument TypeTitleIssuer/Entity
13 May 2013 Rating Action Moody's assigns Baa1 rating to Covidien's new senior note offering; stable outlook Covidien International Finance S.A.
26 Apr 2013 Announcement Moody's: Surge in bond issuance is credit positive for Spanish high-yield corporates Abengoa S.A.
Administrador d...
Atento Inversio...
Avincis Mission...
Befesa Zinc, S....
Cableuropa S.A....
Campofrio Food ...
Cirsa Gaming Co...
Codere S.A.
Corp. Reser. Es...
...
26 Apr 2013 Sector Comment Surge in Spanish High-Yield Corporate Bond Issuance Diversifies Funding, Reduces Refinancing Risks Abengoa S.A.
Administrador d...
Atento Inversio...
Avincis Mission...
Befesa Zinc, S....
Cableuropa S.A....
Campofrio Food ...
Cirsa Gaming Co...
Codere S.A.
Corp. Reser. Es...
...
20 Dec 2012 Credit Opinion Merck KGaA Merck KGaA
Millipore Corpo...
19 Dec 2012 Rating Action Moody's upgrades Merck KGaA to Baa1; stable outlook Merck Financial...
Merck KGaA
Merck-Finanz AG
Millipore Corpo...
14 Dec 2012 Credit Opinion Covidien International Finance S.A. Covidien International Finance S.A.
04 Dec 2012 Announcement Moody's puts Baxter's A3 rating on review for downgrade following Gambro announcement Baxter Holding ...
Baxter Internat...
21 Nov 2012 Credit Opinion Octapharma Nordic AB Octapharma Nordic AB
24 Oct 2012 Rating Methodology Global Medical Product and Device Industry
25 Sep 2012 Rating Action Moody's assigns definitive instrument ratings to Boston Luxembourg II S.a.r.l. (BSN Medical); B2 CFR remains unchanged Boston Luxembourg II S.a.r.l.
    © 2013 Moody's Investors Service, Inc., Moody’s Analytics, Inc. and/or their affiliates and licensors. All rights reserved.
    Regional Sites: